Virtual reality tested as pain relief for advanced breast cancer
NCT ID NCT07497451
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether virtual reality (VR) guided imagery can reduce pain in people with stage III or IV breast cancer. Ninety participants will be split into three groups: one using immersive VR (headset), one using non-immersive VR (computer screen), and a control group receiving standard care. Pain levels will be measured before and after a single 45-minute session to see if VR provides extra relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- virtual reality guided imagery (non-immersive and immersive)
- What this could lead to
- If it works, this could offer a drug-free way to help manage cancer pain alongside standard treatments.
- What could go wrong
- This is a small, early-stage study (90 people) that only measures pain right after a single session. It may not show lasting benefits or work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Middle east university
Amman, 11831, Jordan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Step drug combo outsmart advanced HER2-Positive breast cancer?
- Hidden risk: could opioid misuse be overlooked in cancer care?
- Can a pill combo outpace chemotherapy for aggressive breast cancer?
- Blood tests could reveal hidden resistance in breast cancer
- Triple threat: three new targeted drugs join forces with immunotherapy to attack Hard-to-Treat breast cancer
- Could common painkillers boost opioid effectiveness for cancer patients?